VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer
Shitu Chen(Zhejiang University), Lisong Teng(First Affiliated Hospital Zhejiang University), Xumeng Wang(Nankai University), Yongfeng Ding(Zhejiang University), Irene M. Min(Houston Methodist), Xingyun Su(Blood Center of Zhejiang Province), Xiaodong Teng(Wannan Medical College), Thomas J. Fahey(NewYork–Presbyterian Hospital), Tuo Zhang(Cornell University), Weibin Wang(Southwest Forestry University), Jiang Cao(Second Affiliated Hospital of Zhejiang University), Zhuochao Mao(Zhejiang University), Xiaoxia Jiang(Hangzhou Women’s Hospital)
Cited by 18
Related Papers
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
|Nature Medicine|2018|927
Cloning and Functional Expression of the Human Histamine H<sub>3</sub>Receptor
|Molecular Pharmacology|1999|700
A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone
|Nature Protocols|2010|651
Cloning and Pharmacological Characterization of a Fourth Histamine Receptor (H<sub>4</sub>) Expressed in Bone Marrow
|Molecular Pharmacology|2001|408
American Association of Endocrine Surgeons Guidelines for Adrenalectomy
|JAMA Surgery|2022|224